NCT07502118
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT07502118
Title NexCAR19 (Talikabtagene Autoleucel) in Relapsed/Refractory B-Cell Malignancies (NexCAR19) (NexCAR19)
Acronym NexCAR19
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Health Institutes of Turkey
Indications
Therapies
Age Groups: adult | senior
Covered Countries TUR


No variant requirements are available.